Digital twin for liver cancer: could computer simulations make radiation therapy more precise?
NCT ID NCT07315633
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is developing a computer-based planning tool to make transarterial radioembolization (TARE) more predictable for liver cancer patients. TARE delivers tiny radioactive beads directly to tumors, but results vary due to complex blood vessel patterns. Researchers will create digital models of each patient's liver arteries and simulate how the beads flow, aiming to help doctors choose the best catheter position and injection speed. The study involves 80 adults with liver cancer who are already scheduled for TARE, and uses their existing medical scans to build the models.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radioactive microspheres (via transarterial radioembolization)
- What this could lead to
- If successful, this could lead to a digital tool that helps doctors plan more precise and effective liver cancer treatments, potentially improving outcomes and reducing damage to healthy tissue.
- What could go wrong
- This is an early-stage study focused on building and validating computer models, not testing a new treatment. The models may not perfectly predict real-world results, and any future benefits are years away.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Ghent
RECRUITINGGhent, 9000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple therapy shrink untreatable liver tumors?
- Can an epidural pump beat IV painkillers after liver surgery?
- Could a two-vein embolization trick turn inoperable liver tumors into operable ones?
- Breath of life: new test could sniff out gut cancers before they spread
- Could MRI replace CT for sharper cancer radiation planning?
- Immune cell therapy takes on untreatable liver cancer